Assignee
SULFATEQ BV
NL·8 granted patents·6 pending applications·8 citations·filing 2013–2023
Top patents by PatentIndex Score
14 records- 0176US11006626B2Compounds for protection of cellsSULFATEQ BV·Filed 2018·Granted May 18, 2021·1 cites·5 claims
- 0276US10676452B2Compound for the prophylaxis or treatment of organ damageSULFATEQ BV·Filed 2016·Granted Jun 9, 2020·2 cites·2 claims
- 0373US9913841B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2015·Granted Mar 13, 2018·2 cites·8 claims
- 0472US10123529B2Compounds for protection of cellsSULFATEQ BV·Filed 2013·Granted Nov 13, 2018·2 cites·1 claims
- 0567US12156862B2Medicaments for the treatment of vasoconstriction related diseases or disordersSULFATEQ BV·Filed 2018·Granted Dec 3, 2024·1 cites·10 claims
- 0664US2021227822A1Compounds for protection of cellsSULFATEQ BV·Filed 2021·Application pending·0 cites
- 0756US2025177384A1Chromanol compounds for treatment or prophylaxis of ageing-associated disordersSULFATEQ BV·Filed 2023·Application pending·0 cites
- 0855US10322124B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2018·Granted Jun 18, 2019·0 cites·8 claims
- 0953US10426771B26-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseasesSULFATEQ BV·Filed 2018·Granted Oct 1, 2019·0 cites·8 claims
- 1053US2021024485A1Compound for the prophylaxis or treatment of organ damageSULFATEQ BV·Filed 2020·Application pending·0 cites
- 1150US2023330060A1Compounds for treatment of heart failureSULFATEQ BV·Filed 2021·Application pending·0 cites
- 1248US2023202997A1Chromanol, quinone or hydroquinone compounds for treatment of sepsisSULFATEQ BV·Filed 2021·Application pending·0 cites
- 1346US2023052152A1Compounds for treatment of alzheimer's diseaseSULFATEQ BV·Filed 2020·Application pending·0 cites
- 1440US11730741B26-chromanol derivatives for use as a medicamentSULFATEQ BV·Filed 2018·Granted Aug 22, 2023·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →